Krebs Biochemicals And Industries Ltd
KREBSBIO (NSE)

107.00

229.19
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Krebs Biochemicals And Industries Ltd stands at 3 against 2, three months back.

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures various products, such as Androstenedione for use as Steroid Intermediate, and Lovastatin and Simvastatin for anti-cholesterol. The Company's products in either pilot or research and development stages include Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan and Phenylephrine. The Company has two manufacturing facilities one at Regadichelika, Nellore; and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam, Andhra Pradesh, India.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
126.21
100 DMA ()
141.09
200 DMA ()
157.28
52 Weeks Range
98.35
227.90
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity